GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
38.15 NOK
+0.15 (+0.39%)
Last: Mar 11, 2026, 04:19 PM
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall GENT gets a fundamental rating of 6 out of 10. We evaluated GENT against 65 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT has a decent growth rate and is not valued too expensively.
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- In the past year GENT was profitable.
- In the past year GENT had a positive cash flow from operations.
- In multiple years GENT reported negative net income over the last 5 years.
- In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- GENT has a Return On Assets of 5.13%. This is in the better half of the industry: GENT outperforms 66.15% of its industry peers.
- GENT has a Return On Equity of 6.47%. This is comparable to the rest of the industry: GENT outperforms 47.69% of its industry peers.
- With a decent Return On Invested Capital value of 8.73%, GENT is doing good in the industry, outperforming 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROIC | 8.73% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 7.51%, GENT perfoms like the industry average, outperforming 55.38% of the companies in the same industry.
- GENT has a better Operating Margin (14.42%) than 66.15% of its industry peers.
- The Gross Margin of GENT (55.64%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of GENT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
2. GENT.OL Health Analysis
2.1 Basic Checks
- GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- GENT has an Altman-Z score of 7.65. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
- GENT's Altman-Z score of 7.65 is amongst the best of the industry. GENT outperforms 90.77% of its industry peers.
- GENT has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
- GENT has a better Debt to FCF ratio (0.61) than 93.85% of its industry peers.
- A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.09, GENT belongs to the top of the industry, outperforming 81.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 7.65 |
ROIC/WACC1.02
WACC8.53%
2.3 Liquidity
- A Current Ratio of 5.40 indicates that GENT has no problem at all paying its short term obligations.
- GENT has a better Current ratio (5.40) than 98.46% of its industry peers.
- A Quick Ratio of 3.81 indicates that GENT has no problem at all paying its short term obligations.
- GENT's Quick ratio of 3.81 is amongst the best of the industry. GENT outperforms 95.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 |
3. GENT.OL Growth Analysis
3.1 Past
- GENT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.75%.
- GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.07%.
- The Revenue has been growing by 22.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
3.2 Future
- The Earnings Per Share is expected to grow by 79.21% on average over the next years. This is a very strong growth
- Based on estimates for the next years, GENT will show a quite strong growth in Revenue. The Revenue will grow by 19.00% on average per year.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 44.88 indicates a quite expensive valuation of GENT.
- GENT's Price/Earnings ratio is in line with the industry average.
- GENT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
- The Price/Forward Earnings ratio is 14.28, which indicates a correct valuation of GENT.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT indicates a rather cheap valuation: GENT is cheaper than 81.54% of the companies listed in the same industry.
- GENT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.88 | ||
| Fwd PE | 14.28 |
4.2 Price Multiples
- 61.54% of the companies in the same industry are more expensive than GENT, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 80.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.48 | ||
| EV/EBITDA | 14.45 |
4.3 Compensation for Growth
- GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%
5. GENT.OL Dividend Analysis
5.1 Amount
- GENT has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
- In the last 3 months the price of GENT has falen by -34.26%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- GENT's Dividend Yield is a higher than the industry average which is at 1.01.
- Compared to an average S&P500 Dividend Yield of 1.82, GENT has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 46.54% of the earnings are spent on dividend by GENT. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (3/11/2026, 4:19:47 PM)
38.15
+0.15 (+0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap588.27M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (68.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-17.56%
Revenue NY rev (3m)-17.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.88 | ||
| Fwd PE | 14.28 | ||
| P/S | 3.33 | ||
| P/FCF | 18.48 | ||
| P/OCF | 13.81 | ||
| P/B | 2.87 | ||
| P/tB | 3.48 | ||
| EV/EBITDA | 14.45 |
EPS(TTM)0.85
EY2.23%
EPS(NY)2.67
Fwd EY7%
FCF(TTM)2.06
FCFY5.41%
OCF(TTM)2.76
OCFY7.24%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.22
PEG (5Y)N/A
Graham Number15.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROCE | 11.34% | ||
| ROIC | 8.73% | ||
| ROICexc | 16.54% | ||
| ROICexgc | 23.72% | ||
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% | ||
| FCFM | 18.03% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 118.04% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.21% | ||
| Profit Quality | 240.13% | ||
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 | ||
| Altman-Z | 7.65 |
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
How financially healthy is GENTIAN DIAGNOSTICS ASA?
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.